Presence of impurities in drug substance can have significant impact on the quality, safety and efficacy. Hence it was felt necessary to develop an accurate, rapid, selective and sensitive method for the determination of EPM and its process impurities. The newly developed method was validated according to ICH guidelines13 and 14 considering four impurities to demonstrate specificity, precision, linearity and accuracy of the method. The investigated samples EPM and its Process impurities were supplied by Ogene Systems (I) Pvt. Ltd., Hyderabad, India. The HPLC grade acetonitrile, methanol, ortho phosphoric acid and Ammonium acetate were purchased from Merck Specialty

Chemicals, India. Water used was obtained by Milli Q water purification system. EPM and its impurities were determined by Agilent 1200 series HPLC with PDA detector (Agilent Technologies, BMS-354825 manufacturer Deutschland, Waldron, Germany) instrument with EZ-Chrome elite software.

A phenomenex Gemini–C18 (250 mm × 4.6 mm × 5.0 μm, Phenomenex, Torrance, CA, USA) column was employed for the separation of impurities from EPM. Separation was achieved using a gradient mobile phase 10 mM ammonium acetate in water. pH is adjusted to 3.0 with acetic acid as solvent–A and Acetonitrile as solvent–B in gradient mode (Time/Sol-A: B) 0–5/80: 20, 9/60: 40, 17–28/15: 85, 32–35/80: 20 (v/v). The flow rate of the mobile phase was set to 1.0 mL/min with detected wavelength fixed at 250 nm. The injection volume was 10 μl. Methanol was used as Dabrafenib nmr diluent. The LC–MS/MS analysis has performed on Quattro Micro™

API mass spectrophotometer (Waters, Seoul, Korea). The analysis was performed in the scan mode with electrospray ionization source (ES+) and triple Quadrapole mass analyzer. The analysis parameters for capillary, cone voltage were 3.50 kV and 25 V, respectively. Source, dessolvation gas temperatures were 95 °C and 350 °C, dessolvation gas flow fixed at 450 L/h. The mass spectrum data was processed by using Mass Lynx software. The 1H and 13C NMR experiments were performed in DMSO at 25 °C temperature using mercury plug 300 MHz FT NMR spectrometer, Bruker, Bio Spin Corporation, Billerica, MA, USA. The 1H and 13C chemical shifts Sclareol were reported on the δ scale in ppm relative to tetra methyl silane and DMSO, respectively. 1.0 mg/mL EPM was prepared by dissolving 10.0 mg in 10 mL of diluent for determination of purity. 0.15% impurities blend solution was spiked w.r.t. 1 mg/mL of EPM was prepared in diluent (Fig. 2) (Methanol was used as the diluent). The main target of the method is to identify the possible process impurities and get well resolutions between EPM and its process impurities. The blend solution of 0.15% EPM process impurities was prepared by spiking to 1.0 mg/mL EPM test solution and it was run through C18 column with phosphate buffer in the pH range of 3.0–6.0 along with acetonitrile. Best results were achieved using phenomenex Gemini–C18 (250 mm × 4.6 mm × 5.